Comparison of functional efficacy of surfactant protein B analogues in lavaged rats

Leakage of plasma proteins into the alveoli inhibits pulmonary surfactant function and worsens respiratory failure. Surfactant protein B (SP-B), is essential for surfactant function, but the N-terminal domain of human SP-B (residues 1.25, SP-B1-25) can mimic the biophysical properties of full length SP-B1-78 in vitro. The authors compared the function and inhibition resistance of synthetic surfactant preparations containing SP-B analogues to a natural bovine surfactant preparation "Survanta". Eight groups of eight rats were lavaged to induce surfactant deficiency, fibrinogen was instilled as a surfactant inhibitor, and then they were rescued with exogenous surfactant. Five experimental surfactants were formulated by mixing 3% SP-B1-78, or an equimolar amount of SP-B1-25 and/or 1% palmitoylated surfactant protein C (SP-C)1-35, into a standard phospholipid (PL) mixture: B1-78, B1-25, C1-35, B1-78+C1-35, and B1-25+C1-35 surfactant preparations. Survanta was used as a positive control and PL and no treatment as a negative control. Lung function was assessed during a 2-h period using arterial blood gas and lung compliance measurements. Rats treated with B1-25+C1-35 surfactant and Survanta maintained the highest oxygenation and lung compliance values throughout the experiments. The surfactants could be ranked as B1-25+C1-35 surfactant and Survanta >B1-25 and B1-78+C1-35 surfactants >others. Because the N-terminal domain of surfactant protein B1-25 can improve inhibition resistance, it may be able to substitute for surfactant protein B in exogenous surfactant preparations.

This article has been cited by other articles:

				S. Choe, R. Chang, J. Jeon, and A. Violi Molecular Dynamics Simulation Study of a Pulmonary Surfactant Film Interacting with a Carbonaceous Nanoparticle Biophys. J., November 1, 2008; 95(9): 4102 - 4114. [Abstract] [Full Text] [PDF]

				A. Almlen, G. Stichtenoth, B. Linderholm, M. Haegerstrand-Bjorkman, B. Robertson, J. Johansson, and T. Curstedt Surfactant proteins B and C are both necessary for alveolar stability at end expiration in premature rabbits with respiratory distress syndrome J Appl Physiol, April 1, 2008; 104(4): 1101 - 1108. [Abstract] [Full Text] [PDF]

				Y. P. de Visser, F. J. Walther, E. H. Laghmani, S. van Wijngaarden, K. Nieuwland, and G. T. M. Wagenaar Phosphodiesterase-4 inhibition attenuates pulmonary inflammation in neonatal lung injury Eur. Respir. J., March 1, 2008; 31(3): 633 - 644. [Abstract] [Full Text] [PDF]

				S. A. J. ter Horst, F. J. Walther, B. J. H. M. Poorthuis, P. S. Hiemstra, and G. T. M. Wagenaar Inhaled nitric oxide attenuates pulmonary inflammation and fibrin deposition and prolongs survival in neonatal hyperoxic lung injury Am J Physiol Lung Cell Mol Physiol, July 1, 2007; 293(1): L35 - L44. [Abstract] [Full Text] [PDF]

				S. A. J. ter Horst, G. T. M. Wagenaar, E. de Boer, M. A. van Gastelen, J. C. M. Meijers, B. J. Biemond, B. J. H. M. Poorthuis, and F. J. Walther Pentoxifylline reduces fibrin deposition and prolongs survival in neonatal hyperoxic lung injury J Appl Physiol, November 1, 2004; 97(5): 2014 - 2019. [Abstract] [Full Text] [PDF]

				R. V. Diemel, M. M. E. Snel, A. J. Waring, F. J. Walther, L. M. G. van Golde, G. Putz, H. P. Haagsman, and J. J. Batenburg Multilayer Formation upon Compression of Surfactant Monolayers Depends on Protein Concentration as Well as Lipid Composition. AN ATOMIC FORCE MICROSCOPY STUDY J. Biol. Chem., June 7, 2002; 277(24): 21179 - 21188. [Abstract] [Full Text] [PDF]

				L. M. Nogee Abnormal Expression of Surfactant Protein C and Lung Disease Am. J. Respir. Cell Mol. Biol., June 1, 2002; 26(6): 641 - 644. [Full Text] [PDF]

				S. Chinn Statistics for the European Respiratory Journal Eur. Respir. J., August 1, 2001; 18(2): 393 - 401. [Abstract] [Full Text] [PDF]